Resumen de acción YPSN
Ypsomed Holding AG, junto con sus filiales, desarrolla, fabrica y vende sistemas de inyección e infusión para empresas farmacéuticas y biotecnológicas.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Ypsomed Holding AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CHF329.00 |
| 52 Week High | CHF389.50 |
| 52 Week Low | CHF208.00 |
| Beta | 0.98 |
| 1 Month Change | -8.74% |
| 3 Month Change | 7.69% |
| 1 Year Change | 55.19% |
| 3 Year Change | 117.88% |
| 5 Year Change | 140.15% |
| Change since IPO | 344.59% |
Noticias y actualizaciones recientes
Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital
Apr 07
Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?
Mar 09Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today
Feb 07We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt
Jan 23Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear
Jan 08Recent updates
Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital
Apr 07Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?
Mar 09Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today
Feb 07We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt
Jan 23Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear
Jan 08Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Dec 23Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?
Dec 05Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?
Sep 28Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
Sep 10Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital
Aug 23Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?
Aug 08Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?
Jun 13Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
May 28What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?
May 06Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital
Apr 21At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?
Feb 01These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well
Jan 17Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?
Dec 27Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings
Nov 24What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?
Oct 19Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching
Jul 14Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jun 20Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?
Feb 28Rentabilidad de los accionistas
| YPSN | CH Medical Equipment | Mercado CH | |
|---|---|---|---|
| 7D | -9.9% | -4.8% | -1.4% |
| 1Y | 55.2% | 1.6% | -3.6% |
Rentabilidad vs. Industria: YPSN superó al sector Swiss Medical Equipment , que obtuvo un rendimiento del 5% el año pasado.
Rentabilidad vs. Mercado: YPSN superó al mercado Swiss, que obtuvo un rendimiento del -2.5% el año pasado.
Volatilidad de los precios
| YPSN volatility | |
|---|---|
| YPSN Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.2% |
| 10% least volatile stocks in CH Market | 2.0% |
Precio estable de las acciones: YPSN no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de YPSN (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1984 | 2,200 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, junto con sus filiales, desarrolla, fabrica y vende sistemas de inyección e infusión para empresas farmacéuticas y biotecnológicas. La empresa opera a través de dos segmentos, Ypsomed Delivery Systems e Ypsomed Diabetes Care. El segmento Ypsomed Delivery Systems suministra diversos sistemas de inyección, como inyectores-bolígrafo, autoinyectores e inyectores portátiles, así como otros dispositivos inteligentes.
Resumen de fundamentos de Ypsomed Holding AG
| Estadísticas fundamentales de YPSN | |
|---|---|
| Capitalización bursátil | CHF4.49b |
| Beneficios(TTM) | CHF72.42m |
| Ingresos (TTM) | CHF508.61m |
62.0x
Ratio precio-beneficio (PE)8.8x
Ratio precio-ventas (PS)¿Está YPSN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de YPSN | |
|---|---|
| Ingresos | CHF508.61m |
| Coste de los ingresos | CHF345.64m |
| Beneficio bruto | CHF162.96m |
| Otros gastos | CHF90.55m |
| Beneficios | CHF72.42m |
Últimos beneficios comunicados
Sep 30, 2023
Próxima fecha de beneficios
May 22, 2024
| Beneficios por acción (BPA) | 5.31 |
| Margen bruto | 32.04% |
| Margen de beneficio neto | 14.24% |
| Ratio deuda/patrimonio | 35.4% |
¿Cómo se ha desempeñado YPSN a largo plazo?
Ver rendimiento histórico y comparativa